Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31)

Transplantation
W J TaxR A Koene

Abstract

Anti-CD3 monoclonal antibody (mAb) OKT3 is immunosuppressive, but causes severe adverse effects during the first administration ("first-dose reaction"). These adverse effects are presumably caused by cytokine release that results from T-cell activation. In vitro, T-cell activation by anti-CD3 mAb requires interaction with monocyte Fc receptors. The Fc receptor for murine IgG1, Fc gammaRIIa, is polymorphic. In some individuals, murine IgG1 anti-CD3 mAb causes T-cell proliferation and cytokine release in vitro (high responders [HR]), whereas in individuals with the low-responder (LR) phenotype it does not. We have now investigated the role of this Fc gammaRIIa polymorphism in the release of cytokines in vivo and the occurrence of adverse effects after the administration of WT31, a murine IgG1 anti-CD3/T cell receptor mAb. WT31 caused an increase of plasma tumor necrosis factor-alpha in all four HR patients and none of the five LR patients. In all HR patients except one, plasma gamma-interferon and interleukin 6 also increased, and a first-dose response was observed, whereas no cytokine release or adverse effects occurred in any of the LR patients. WT31 caused lymphopenia in all HR and none of the LR patients. FACS analysis demons...Continue Reading

References

May 1, 1991·Journal of Leukocyte Biology·J G van de Winkel, C L Anderson
Apr 25, 1991·Journal of Immunological Methods·W JiskootE C Beuvery
Jan 1, 1989·Annual Review of Immunology·B Beutler, A Cerami
Feb 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J R ThistlethwaiteF P Stuart
Nov 1, 1982·European Journal of Immunology·L ChatenoudJ F Bach
Jun 1, 1994·The Journal of Clinical Investigation·K J ParlevlietP T Schellekens

❮ Previous
Next ❯

Citations

Feb 17, 2009·Current Oncology Reports·Steve C LeeRobert L Ferris
Dec 26, 2001·Transplantation Proceedings·E BertoniM Salvadori
Dec 21, 2002·Transplantation Proceedings·A PawlikB Gawronska-Szklarz
Dec 5, 1998·Transplantation Proceedings·H DegawaT Nagao
Dec 30, 2006·Nature Reviews. Drug Discovery·Vibeke StrandJohn D Isaacs
Sep 17, 2004·Transplantation·Fang F YuanJeremy R Chapman
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert L FerrisSoldano Ferrone
May 19, 2010·Expert Review of Clinical Immunology·Peter J BugelskiEsther Bouman-Thio
Nov 20, 2015·Journal of Pediatric Hematology/oncology·Mark WilliamsRobert Wynn
Dec 18, 2004·Journal of Immunological Methods·Annet van Royen-KerkhofJan G J van de Winkel
Jul 15, 2004·Transplantation Proceedings·A PawlikB Gawronska-Szklarz
Jul 1, 1997·The Journal of Laboratory and Clinical Medicine·S BuysmannI J ten Berge
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nai-Kong V CheungRichard Gorlick
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sumiaki TanakaRobert P Kimberly
Aug 22, 2003·Clinical and Experimental Immunology·L Renders, T Valerius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.